AUPH peer analysis
Aurinia Pharmaceuticals (AUPH) against its competitors: price, today's move, 1-year return and market value side by side.
AUPH and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.78 | -4.79% | 51.81% | $615.29M |
| ALMS Alumis | $6.37 | -5.35% | 36.70% | – |
| ATTO Attovia Therapeutics | $15.19 | -0.52% | – | $693.44M |
| BHVN Biohaven | $15.14 | -1.78% | -12.91% | $2.33B |
| ELDN Eledon Pharmaceuticals | $2.77 | -8.88% | -36.32% | – |
| EVMN Evommune | $6.73 | -1.17% | – | – |
| MLTX MoonLake | $11.46 | -2.72% | 16.82% | – |
| TRAX First Tracks Biotherapeutics | $44.98 | -0.22% | – | – |
| VERA Vera Therapeutics | $30.26 | -2.32% | 1.99% | – |
| AUPH Aurinia Pharmaceuticals | $16.11 | -3.24% | 32.92% | $2.23B |
- AUPH's peers: ACRS (Aclaris Therapeutics), ALMS (Alumis), ATTO (Attovia Therapeutics), BHVN (Biohaven), ELDN (Eledon Pharmaceuticals), EVMN (Evommune), MLTX (MoonLake), TRAX (First Tracks Biotherapeutics).
Updated 2026-11-02 23:14 UTC